Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia.
Arantes LH Jr, Crawford J, Gascon P, Latymer M, Launay-Vacher V, Rolland C, Scotte F, Wish J. Arantes LH Jr, et al. Among authors: gascon p. Crit Rev Oncol Hematol. 2018 Sep;129:79-90. doi: 10.1016/j.critrevonc.2018.06.010. Epub 2018 Jun 19. Crit Rev Oncol Hematol. 2018. PMID: 30097240 Free article. Review.
Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim.
Gascón P, Aapro M, Ludwig H, Rosencher N, Turner M, Song M, MacDonald K, Lee C, Muenzberg M, Abraham I. Gascón P, et al. Crit Rev Oncol Hematol. 2011 Mar;77(3):184-97. doi: 10.1016/j.critrevonc.2010.01.014. Epub 2010 Mar 1. Crit Rev Oncol Hematol. 2011. PMID: 20189821
Clinical evaluation and optimal management of cancer cachexia.
Tuca A, Jimenez-Fonseca P, Gascón P. Tuca A, et al. Among authors: gascon p. Crit Rev Oncol Hematol. 2013 Dec;88(3):625-36. doi: 10.1016/j.critrevonc.2013.07.015. Epub 2013 Aug 15. Crit Rev Oncol Hematol. 2013. PMID: 23953794 Review.
324 results